Sarepta Therapeutics, Inc. SRPT Business Segments — Facility And Technology Related Expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:FacilityAndTechnologyRelatedExpenses.
The official record: Sarepta Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses?
- Sarepta Therapeutics, Inc. (SRPT) reported business segments — facility and technology related expenses of $22.94M in Q1 2026.
- How has Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses changed year-over-year?
- Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses decreased by 17.0% year-over-year, from $27.66M to $22.94M.
- What is the long-term trend for Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses?
- Over 3 years (2022 to 2025), Sarepta Therapeutics, Inc.'s business segments — facility and technology related expenses has grown at a 14.1% compound annual growth rate (CAGR), from $71.7M to $106.46M.
- What does business segments — facility and technology related expenses mean?
- Covers the overhead costs associated with maintaining physical facilities and the technological infrastructure required to support segment operations. This metric highlights the fixed cost burden and digital investment levels of the business unit.